TGFB1 and mesothelioma: A mouse model of subcutaneous mesothelioma tumors treated with a TGF-β inhibitor proved that neutrophils support the growth of tumor cells by inhibiting CD8+ T cells in the untreated group, while opposed the tumor growth through cytotoxic ability in the TGF-β-treated group.